Greetings FPC folks,
First, a UroToday presentation with Drs Oliver Sartor, Neal Shore, Alicia Morgans, and Phillip Koo--RO at MD Anderson. This presentation goes into how the newer scans are "10-100X better than traditional scans". They go on to discuss OSPREY trial and the ORIOLE trial, and treatment options. As Sartor stated about the ORIOLE trial-- "In conclusion SABR, stereotactic body radiotherapy, or SBRT improves PFS in men with oligometastatic prostate cancer when using conventional imaging compared to observation alone, but total consolidation of PSMA radiotracer-avid lesions gives stronger results. And that's the punchline from this ORIOLE trial."
urotoday.com/video-lectures...
Next, the FDA approves a new and better scan--the F18 DCFPyl scan--from Onclive:
onclive.com/view/fda-approv...
With the newer scan approved, this will allow oligometastatic patients to get a better scan, and treat all lesions that can be seen giving stronger results for patients.
Incredible....that Science....
Don Pescado